(Q34620091)

3 August 2017

title

Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase (English)

1 reference

3 August 2017

1 reference

1 reference

Tod P Holler

1

1 reference

3 August 2017

Tanya Parkinson

series ordinal

2

1 reference

3 August 2017

David C Pryde

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

Expert Opinion on Drug Discovery

3 August 2017

published in

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

293-314

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Antiviral therapy: chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Novel hepatitis C drugs in current trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Hepatitis C protease and polymerase inhibitors in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3-4A protease at low enzyme concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

A continuous nonradioactive assay for RNA-dependent RNA polymerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

In Vitro Selection and Characterization of Hepatitis C Virus Serine Protease Variants Resistant to an Active-Site Peptide Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

In vitro selected Con1 subgenomic replicons resistant to 2'-C-methyl-cytidine or to R1479 show lack of cross resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

In Vitro Resistance Study of AG-021541, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

In vitro characterization of a purified NS2/3 protease variant of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

A collaborative screening program for the discovery of inhibitors of HCV NS2/3 cis-cleaving protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Structure of the catalytic domain of the hepatitis C virus NS2-3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

NS3 helicase actively separates RNA strands and senses sequence barriers ahead of the opening fork

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Viral and cellular RNA helicases as antiviral targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

A novel high throughput screening assay for HCV NS3 helicase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Detection of hepatitis C virus helicase activity using the scintillation proximity assay system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Direct fluorometric measurement of hepatitis C virus helicase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Hepatitis C virus NS4A inhibits cap-dependent and the viral IRES-mediated translation through interacting with eukaryotic elongation factor 1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Palmitoylation and Polymerization of Hepatitis C Virus NS4B Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Hepatitis C virus NS5A: tales of a promiscuous protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

NS5A--from obscurity to new target for HCV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Host cell factor requirement for hepatitis C virus enzyme maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase/helicase: Synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl)imidazole-1-β-d-ribofuranoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Searching for a new anti-HCV therapy: synthesis and properties of tropolone derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

NS3 Peptide, a Novel Potent Hepatitis C Virus NS3 Helicase Inhibitor: Its Mechanism of Action and Antiviral Activity in the Replicon System

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Selection of Replicon Variants Resistant to ACH-806, a Novel Hepatitis C Virus Inhibitor with No Cross-Resistance to NS3 Protease and NS5B Polymerase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Synergy of a Hepatitis C Virus (HCV) NS4A Antagonist in Combination with HCV Protease and Polymerase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460440902762802

10.1517/17460440902762802

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference